NEW YORK (GenomeWeb) – NuGen Technologies plans to develop new applications for its proprietary target enrichment technology for next-gen sequencing, including the analysis of copy number variants, viral integration sites, and methylation sites.
Over the past year, the company has commercialized its method, called single-primer enrichment technology (SPET), for a number of applications to analyze both DNA and RNA, including single nucleotide variant and indel detection and gene fusion identification.